Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
Cardiology Journal|October 9, 2012
Do statins influence platelet reactivity on acetylsalicylic acid therapy in patients with type 2 diabetes?Marek Postula, Marek Rosiak, Agnieszka Kaplon-Cieslicka, et al.Cellular and Molecular Neurobiology|March 31, 2025
Extracellular Vesicle-Derived miRNAs in Ischemic Stroke: Roles in Neuroprotection, Tissue Regeneration, and Biomarker PotentialCeren Eyileten, Pamela Czajka, Izabela Domitrz, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|November 23, 2022
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart functionAndleeb Shahzadi, Ceren Eyileten, Marek Postula, et al.Journal of Molecular and Cellular Cardiology|July 7, 2019
MicroRNAs fingerprint of bicuspid aortic valveJolanda Sabatino, Zofia Wicik, Salvatore De Rosa, et al.Journal of Clinical Medicine|April 17, 2020
Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination TypeCeren Eyileten, Marek Postula, Daniel Jakubik, et al.Thrombosis Research|September 30, 2009
Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control studyZenon Huczek, Krzysztof J Filipiak, Janusz Kochman, et al.Journal of Thrombosis and Haemostasis : JTH|December 17, 2025
Impact of direct oral anticoagulants on target lesion revascularization rates in patients with chronic coronary syndromeChristof Skos, Jovan Rogozarski, Marek Postula, et al.Frontiers in Cardiovascular Medicine|December 19, 2019
Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity TestingMałgorzata Ostrowska, Jacek Kubica, Piotr Adamski, et al.Journal of Clinical Medicine|November 25, 2020
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk FactorsZofia Wicik, Ceren Eyileten, Daniel Jakubik, et al.BMC Medicine|November 5, 2019
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroupsGeorg Gelbenegger, Marek Postula, Ladislav Pecen, et al.Pageof 8